Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elaine A Sugarman"'
Autor:
Brynn Levy, Lei Tan, David-Emlyn Parfitt, Elaine A. Sugarman, Piraye Yurttas Beim, Caterina Clementi, T. Hu-Seliger
Publikováno v:
Journal of assisted reproduction and genetics. 34(12)
Autor:
Elinor Langfelder-Schwind, Elaine A Sugarman, Steven Keiles, Christina Zaleski, Joy B Redman, Trisha Brown, Amy Powers, Sumheda Ghate, Michelle N. Strecker, Rebecca J. Darrah, Barbara A. Karczeski
Publikováno v:
Journal of Genetic Counseling. 23:5-15
To provide practice recommendations for genetic counselors whose clients are considering cystic fibrosis (CF) carrier testing or seeking information regarding CF molecular test results. The goals of these recommendations are to: 1) Provide updated in
Autor:
Ali Cullors, Kahuku Oades, Jorge A. Garces, Elaine A. Sugarman, Joel Centeno, David Taylor, Juan-Sebastian Saldivar
Publikováno v:
Pharmacogenomics and Personalized Medicine
The health care costs associated with prescription drugs are enormous, particularly in patients with polypharmacy (taking more than five prescription medications), and they continue to grow annually. The evolution of pharmacogenetics has provided cli
Autor:
Kerry Flynn, Paul Labrousse, Andrew M. Walker, Christopher Sears, Bernice A Allitto, Colin Donohoe, Elizabeth M. Rohlfs, Elaine A Sugarman, Leonid Boguslavskiy, Brant C. Hendrickson, Thomas Scholl, Viatcheslav R. Akmaev
Publikováno v:
Journal of Medical Genetics
Background: Spinal muscular atrophy (SMA) is the most common inherited lethal disease of children. Various genetic deletions involving the bi-allelic loss of SMN1 exon 7 are reported to account for 94% of affected individuals. Published literature pl
Autor:
Ruth A. Heim, Lodercio Culpi, Nelson Rosario, Lairton Valentim, Bernice Allito, John A. Phillips, Norberto Ludwig, Salmo Raskin, Elaine A Sugarman, Fabio R. Faucz, Francisco J.C. Reis, Christian M. Probst, Lilian Pereira
Publikováno v:
Genetic Testing. 7:213-218
Cystic fibrosis (CF) is an autosomal recessive disease caused by at least 1,000 different mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). To determine the frequency of 70 common worldwide CFTR mutations in 155 Euro-B
Autor:
Ruth A. Heim, Bernice A Allitto, Lawrence M. Silverman, Elizabeth M. Rohlfs, Elaine A Sugarman, Michael R. Knowles, Rhonda G. Pace, Zhaoqing Zhou
Publikováno v:
Genetics in Medicine. 4:319-323
Purpose: To determine whether CFTR intragenic changes modulate the cystic fibrosis (CF) phenotype in individuals who are positive for the I148T allele. Methods: The CFTR genes from individuals who carried at least one copy of the I148T allele were an
Autor:
Hui Zhu, Elizabeth M. Rohlfs, Viatcheslav R. Akmaev, Narasimhan Nagan, Kerry Flynn, Zhaoqing Zhou, Deborah Alexa Sirko-Osadsa, Brant C. Hendrickson, Thomas Scholl, Elaine A Sugarman, Bernice A Allitto
Publikováno v:
European Journal of Human Genetics
Spinal muscular atrophy (SMA) is a leading inherited cause of infant death with a reported incidence of ~1 in 10,000 live births and is second to cystic fibrosis as a common, life-shortening autosomal recessive disorder. The American College of Medic
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 13(7)
Spinal muscular atrophy is a common autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron (SMN1) gene, affecting approximately 1 in 10,000 live births. The disease is characterized by progressive symmetrical musc
Autor:
Elinor Langfelder-Schwind, Elaine A Sugarman, Seth Marcus, Joy B Redman, Barbara Pettersen, Kim Jensen, Trisha Brown, Edward M. Kloza
Publikováno v:
Journal of genetic counseling. 14(1)
For over a decade, prenatal screening for cystic fibrosis (CF) has been considered a model for the integration of genetic testing into routine medical practice. Data from pilot studies and public policy discourse have led to recommendations by some p
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 6(5)
To evaluate and quantify indications for CFTR mutation analysis of prenatal specimens, and to determine if a significant portion of tests are performed only for the identification of 5T alleles, we surveyed our laboratory data over a 3-year time peri